Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $973.53 million. The enterprise value is $1.35 billion.
| Market Cap | 973.53M |
| Enterprise Value | 1.35B |
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 44.53 million shares outstanding. The number of shares has decreased by -7.38% in one year.
| Current Share Class | 44.53M |
| Shares Outstanding | 44.53M |
| Shares Change (YoY) | -7.38% |
| Shares Change (QoQ) | -1.08% |
| Owned by Insiders (%) | 9.92% |
| Owned by Institutions (%) | 75.59% |
| Float | 33.28M |
Valuation Ratios
The trailing PE ratio is 10.67 and the forward PE ratio is 6.66. AMPH's PEG ratio is 1.58.
| PE Ratio | 10.67 |
| Forward PE | 6.66 |
| PS Ratio | 1.36 |
| Forward PS | 1.27 |
| PB Ratio | 1.25 |
| P/TBV Ratio | 4.38 |
| P/FCF Ratio | 8.06 |
| P/OCF Ratio | 6.26 |
| PEG Ratio | 1.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.13, with an EV/FCF ratio of 11.14.
| EV / Earnings | 13.77 |
| EV / Sales | 1.88 |
| EV / EBITDA | 6.13 |
| EV / EBIT | 8.26 |
| EV / FCF | 11.14 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 0.83.
| Current Ratio | 4.02 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | 2.85 |
| Debt / FCF | 5.41 |
| Interest Coverage | 5.49 |
Financial Efficiency
Return on equity (ROE) is 12.90% and return on invested capital (ROIC) is 11.19%.
| Return on Equity (ROE) | 12.90% |
| Return on Assets (ROA) | 6.37% |
| Return on Invested Capital (ROIC) | 11.19% |
| Return on Capital Employed (ROCE) | 11.11% |
| Weighted Average Cost of Capital (WACC) | 6.99% |
| Revenue Per Employee | $364,315 |
| Profits Per Employee | $49,643 |
| Employee Count | 1,976 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, AMPH has paid $25.53 million in taxes.
| Income Tax | 25.53M |
| Effective Tax Rate | 20.65% |
Stock Price Statistics
The stock price has decreased by -9.63% in the last 52 weeks. The beta is 0.91, so AMPH's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -9.63% |
| 50-Day Moving Average | 21.48 |
| 200-Day Moving Average | 25.08 |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 443,101 |
Short Selling Information
The latest short interest is 3.90 million, so 8.76% of the outstanding shares have been sold short.
| Short Interest | 3.90M |
| Short Previous Month | 3.53M |
| Short % of Shares Out | 8.76% |
| Short % of Float | 11.73% |
| Short Ratio (days to cover) | 7.77 |
Income Statement
In the last 12 months, AMPH had revenue of $719.89 million and earned $98.09 million in profits. Earnings per share was $2.03.
| Revenue | 719.89M |
| Gross Profit | 356.06M |
| Operating Income | 163.50M |
| Pretax Income | 123.62M |
| Net Income | 98.09M |
| EBITDA | 220.20M |
| EBIT | 163.50M |
| Earnings Per Share (EPS) | $2.03 |
Balance Sheet
The company has $282.81 million in cash and $656.00 million in debt, giving a net cash position of -$373.19 million or -$8.38 per share.
| Cash & Cash Equivalents | 282.81M |
| Total Debt | 656.00M |
| Net Cash | -373.19M |
| Net Cash Per Share | -$8.38 |
| Equity (Book Value) | 788.81M |
| Book Value Per Share | 17.28 |
| Working Capital | 477.86M |
Cash Flow
In the last 12 months, operating cash flow was $156.12 million and capital expenditures -$34.88 million, giving a free cash flow of $121.23 million.
| Operating Cash Flow | 156.12M |
| Capital Expenditures | -34.88M |
| Depreciation & Amortization | 56.70M |
| Net Borrowing | 5.99M |
| Free Cash Flow | 121.23M |
| FCF Per Share | $2.72 |
Margins
Gross margin is 49.46%, with operating and profit margins of 22.71% and 13.63%.
| Gross Margin | 49.46% |
| Operating Margin | 22.71% |
| Pretax Margin | 17.17% |
| Profit Margin | 13.63% |
| EBITDA Margin | 30.59% |
| EBIT Margin | 22.71% |
| FCF Margin | 16.84% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.38% |
| Shareholder Yield | 7.38% |
| Earnings Yield | 10.04% |
| FCF Yield | 12.41% |
Analyst Forecast
The average price target for AMPH is $28.38, which is 29.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.38 |
| Price Target Difference | 29.83% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 4.03% |
| EPS Growth Forecast (5Y) | 4.77% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 2.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.61 |
| Piotroski F-Score | 5 |